Sign in
Garo H. Armen
Photo: CC0, via Wikimedia Commons43

Garo H. Armen

Turkish-born American businessman (born 1953)

Garo H. Armen (Armenian: Կարո Արմեն) is an American businessman. He is the co-founder and CEO of Agenus, Inc, as well as the chairman of the Children of Armenia Fund (COAF).2

From Wikipedia’s article on Garo H. Armen (this version), CC BY-SA 4.0.

Born Jan 31, 1953.1

Companies

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

As of each latest filing. The line shows shares held over time.

Recent filings

Early life and education

  • Date not recordedWashington University in St. Louis3
  • Date not recordedCornell University3

Armen was born in Istanbul, Turkey, in 1953, Armen moved to the United States in 1970. He began his career at Brookhaven National Laboratory after earning his PhD in Physical Chemistry from the City University of New York. He later transitioned to Wall Street, where he founded Armen Partners, a firm specializing in healthcare investments. His efforts resulted in key industry mergers, including the union of Immunex Corporation and Lederle Oncology.

From Wikipedia’s article on Garo H. Armen (this version), CC BY-SA 4.0.

Career

Occupation: chief executive officer, businessperson, entrepreneur, scientist.7

  • Date not recordedFounded Agenus4
  • Date not recordedChief executive, Agenus5
  • Date not recordedChief executive officer6

Armen is the chairman and CEO of Agenus Inc., a biotechnology company he co-founded in 1994, focused on immunotherapies to fight cancer. One of Agenus’ achievements is the development of the BOT/BAL combination therapy, which has demonstrated success in difficult-to-treat cancers, including metastatic colorectal cancer. This therapy reawakens the immune system’s natural ability to fight cancer, representing a significant advancement in the treatment of cancers that were once considered insurmountable.

Armen is also the chairman of Mink Therapeutics, which is developing novel cell therapies that modulate immune responses. These therapies aim to treat both cancer and a range of immune disorders, providing a new approach to managing complex diseases.

He also spearheaded the restructuring of Elan Corporation, guiding the company through a period that ultimately saved it from collapse. He also serves as the executive chairman of Protagenic Therapeutics, a company focused on therapies for neurological and metabolic disorders.

From Wikipedia’s article on Garo H. Armen (this version), CC BY-SA 4.0.

Personal life

  • BornJan 31, 1953, Istanbul8
  • CitizenshipUnited States9

Philanthropy

Armen founded the Children of Armenia Fund (COAF) in 2003. COAF has implemented over $100 million worth of projects, aiming to improve education, healthcare, and social programs across more than 100 villages in rural Armenia.

From Wikipedia’s article on Garo H. Armen (this version), CC BY-SA 4.0.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
    Wikidata and SEC EDGARAgenus, Chief executive officer
  13. 13
  14. 14
  15. 15
    SEC EDGARAgenus, Chair
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43